Search Results - "Carrieri, M P"

Refine Results
  1. 1

    Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time by Cluze, C., Rey, D., Huiart, L., BenDiane, M.K., Bouhnik, A.D., Berenger, C., Carrieri, M.P., Giorgi, R.

    Published in Annals of oncology (01-04-2012)
    “…In premenopausal women with hormone receptor-positive breast cancer (BC), 5 years of tamoxifen is recommended. Little is known about reasons for interruption…”
    Get full text
    Journal Article
  2. 2

    Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort) by Yaya, I., Roux, P., Marcellin, F., Salmon-Ceron, D., Carrieri, M. P.

    Published in Digestive diseases and sciences (01-10-2017)
    “…Comment onEngagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies. [Dig Dis Sci. 2017]…”
    Get full text
    Journal Article
  3. 3

    Adherence to HAART in French HIV-infected injecting drug users : The contribution of buprenorphine drug maintenance treatment by MOATTI, J. P, CARRIERI, M. P, SPIRE, B, GASTAUT, J. A, CASSUTO, J. P, MOREAU, J

    Published in AIDS (London) (28-01-2000)
    “…Objectives: To assess adherence to highly active antiretroviral therapies (HAART) in a cohort of French patients infected by HIV through injection drug use…”
    Get full text
    Journal Article
  4. 4

    Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician by Roux, P, Cohen, J, Lascoux-Combe, C, Sogni, P, Winnock, M, Salmon-Ceron, D, Spire, B, Dabis, F, Carrieri, M.P

    Published in Drug and alcohol dependence (01-07-2011)
    “…Abstract Objectives The objective of this study was to assess to what extent HIV/HCV co-infected patients underreport alcohol use to their physician with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Buprenorphine Use: The International Experience by Carrieri, Maria Patrizia, Amass, Leslie, Lucas, Gregory M., Vlahov, David, Wodak, Alex, Woody, George E.

    Published in Clinical infectious diseases (15-12-2006)
    “…The confluence of the heroin injection epidemic and the human immunodeficiency virus (HIV) infection epidemic has increased the call for expanded access to…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8

    Immunosuppression and Cancer: A Comparison of Risks in Recipients of Organ Transplants and in HIV-Positive Individuals by Busnach, G., Piselli, P., Arbustini, E., Baccarani, U., Burra, P., Carrieri, M.P., Citterio, F., De Juli, E., Bellelli, S., Pradier, C., Rezza, G., Serraino, D.

    Published in Transplantation proceedings (01-12-2006)
    “…The comparison of cancers occurring excessively among HIV-infected and transplanted individuals may help to elucidate the relationship between immune…”
    Get full text
    Journal Article Conference Proceeding
  9. 9
  10. 10
  11. 11

    Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users by CARRIERI, M.P, CHESNEY, M.A, SPIRE, B, LOUNDOU, A, SOBEL, A, LEPEU, G, MOATTI, J.P

    “…The study, carried out in the French MANIF 2000 cohort of HIV positive patients contaminated through injecting drug use, assessed the impact of patients'…”
    Get full text
    Journal Article
  12. 12

    Investigation of a slaughterhouse-related outbreak of Q fever in the French Alps by CARRIERI, M. P, TISSOT-DUPONT, H, REY, D, BROUSSE, P, RENARD, H, OBADIA, Y, RAOULT, D

    “…The aim of the study presented here was to describe the different epidemiological methods used to investigate an outbreak of Q fever that occurred in the…”
    Get full text
    Journal Article
  13. 13

    Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use by Carrieri, M. P., Rey, D., Serraino, D., Trémolières, F., Méchali, D., Moatti, J. P., Spire, B., THE MANIF 2000 STUDY GROUP

    Published in AIDS care (01-10-2006)
    “…Among HIV-infected women, unprotected sex with the main sexual partner is common practice. Conversely, studies about condom use with sexual partners of unknown…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART by Carrieri, M.P, Vlahov, D, Dellamonica, P, Gallais, H, Lepeu, G, Spire, B, Obadia, Y

    Published in Drug and alcohol dependence (01-07-2000)
    “…Some HIV-infected injecting drug users (IDUs) on drug abuse maintenance treatment have access to highly active antiretroviral therapy (HAART); this raises…”
    Get full text
    Journal Article
  16. 16

    Impaired patient‐reported outcomes persist in HIV‐HCV co‐infected patients and in cirrhotic patients despite HCV clearance by Marcellin, F., Morlat, P., Wittkop, L., Salmon‐Ceron, D., Carrieri, M. P.

    Published in Journal of viral hepatitis (01-03-2018)
    “…Dirks et al. 1 's recent study provides greater insight into the neu-ropsychiatric symptoms experienced by HCV-infected patients and questions how these…”
    Get full text
    Journal Article
  17. 17

    Access to Antiretroviral Treatment among French HIV Infected Injection Drug Users: The Influence of Continued Drug Use by Carrieri, M. P., Moatti, J. P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., Chesney, M., The MANIF 2000 Study Group

    “…Study objective-To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among…”
    Get full text
    Journal Article
  18. 18

    A Case-Control Study on Risk Factors for Peyronie’s Disease by Carrieri, Maria Patrizia, Serraino, Diego, Palmiotto, Fabio, Nucci, Giuseppe, Sasso, Francesco

    Published in Journal of clinical epidemiology (01-06-1998)
    “…The aim of this study was to investigate the relationship between history of selected diseases, genital traumas, and Peyronie’s disease. A hospital-based…”
    Get full text
    Journal Article
  19. 19

    Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon by Meresse, M, March, L, Kouanfack, C, Bonono, R‐C, Boyer, S, Laborde‐Balen, G, Aghokeng, A, Suzan‐Monti, M, Delaporte, E, Spire, B, Carrieri, MP, Laurent, C

    Published in HIV medicine (01-09-2014)
    “…Objectives The emergence of HIV drug resistance is a crucial issue in Africa, where second‐line antiretroviral therapy (ART) is limited, expensive and complex…”
    Get full text
    Journal Article
  20. 20